SP cell behaviour has been reported to be regulated at some levels when exposed to endogenous TGF-β1 in several cancers including breast cancer, ovarian cancer and pancreatic cancer [11–13]. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.